Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.

about

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.

Item

http://www.wikidata.org/entity/Q40099619

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Efficacy and safety of switchi ...... pressed HIV-infected patients.

@en

type

Item

label

Efficacy and safety of switchi ...... pressed HIV-infected patients.

@en

prefLabel

Efficacy and safety of switchi ...... pressed HIV-infected patients.

@en

P1476

Efficacy and safety of switchi ...... pressed HIV-infected patients.

@en

P2093

Alessia Carbone

http://www.w3.org/2001/XMLSchema#string

Andrea Andolina

http://www.w3.org/2001/XMLSchema#string

Andrea Poli

http://www.w3.org/2001/XMLSchema#string

Chiara Oltolini

http://www.w3.org/2001/XMLSchema#string

Laura Galli

http://www.w3.org/2001/XMLSchema#string

Michela Franzin

http://www.w3.org/2001/XMLSchema#string

Nadia Galizzi

http://www.w3.org/2001/XMLSchema#string

Patrizia Tadini

http://www.w3.org/2001/XMLSchema#string

P2860

Generic versus brand-name drugs used in cardiovascular diseases

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese HIV/AIDS Patients: Multicentric Observation Cohort

Comparing tolerability and efficacy of generic versus brand alendronate: a randomized clinical study in postmenopausal women with a recent fracture.

Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 > or = 50 cells/mm3.

Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study.

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy

Generic and branded drugs for the treatment of people living with HIV/AIDS.

Brand name versus generic warfarin: a systematic review of the literature.

Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: a 3-year follow-up.

Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection.

P304

e0182007

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0182007

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28763473

http://www.w3.org/2001/XMLSchema#string

P921

virology

P932

5538668

http://www.w3.org/2001/XMLSchema#string